Targeted Medical Pharma, Inc. (TRGM)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 5, 2026
Targeted Medical Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | 2010 - 2008 |
|---|---|---|---|---|---|---|
Period Ending | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | 2010 - 2008 |
| Net Income | -3.04 | -3.9 | -9.34 | -9.59 | -4.18 | Upgrade
|
| Depreciation & Amortization | 0.23 | 0.4 | 0.41 | 0.44 | 0.46 | Upgrade
|
| Other Amortization | 0.34 | 0.43 | 0.38 | 1.99 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.14 | - | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.09 | 0.66 | 0.75 | 1.15 | 1.4 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | - | 0.22 | - | Upgrade
|
| Other Operating Activities | -0.16 | -0.01 | 5.51 | 1.25 | -2.47 | Upgrade
|
| Change in Accounts Receivable | -0.12 | 0.07 | 0.09 | 0.33 | -0.44 | Upgrade
|
| Change in Inventory | 0.03 | 0.47 | -0.12 | 0.02 | -0.13 | Upgrade
|
| Change in Accounts Payable | 0.4 | -0.04 | -0.66 | 1.99 | 3.43 | Upgrade
|
| Change in Income Taxes | - | 0.9 | - | -0.11 | -0.63 | Upgrade
|
| Change in Other Net Operating Assets | 0.8 | 1.8 | 0.94 | -0.07 | -0.03 | Upgrade
|
| Operating Cash Flow | -1.28 | 0.78 | -2.05 | -2.37 | -2.59 | Upgrade
|
| Capital Expenditures | - | - | -0.04 | -0.12 | -0.08 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | -0.08 | -0.18 | -0.43 | Upgrade
|
| Investment in Securities | - | - | - | - | 0.24 | Upgrade
|
| Investing Cash Flow | - | - | -0.12 | -0.29 | -0.27 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 3.14 | 0.6 | Upgrade
|
| Long-Term Debt Issued | 1.95 | 0.13 | 3.04 | - | 1.6 | Upgrade
|
| Total Debt Issued | 1.95 | 0.13 | 3.04 | 3.14 | 2.2 | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.66 | -0.29 | - | Upgrade
|
| Long-Term Debt Repaid | -0.6 | -1.63 | -0.29 | - | - | Upgrade
|
| Total Debt Repaid | -0.6 | -1.63 | -0.95 | -0.29 | - | Upgrade
|
| Net Debt Issued (Repaid) | 1.35 | -1.5 | 2.08 | 2.85 | 2.2 | Upgrade
|
| Issuance of Common Stock | - | 0.24 | 0.25 | - | - | Upgrade
|
| Financing Cash Flow | 1.35 | -1.26 | 2.33 | 2.85 | 2.2 | Upgrade
|
| Net Cash Flow | 0.07 | -0.48 | 0.17 | 0.18 | -0.65 | Upgrade
|
| Free Cash Flow | -1.28 | 0.78 | -2.08 | -2.49 | -2.67 | Upgrade
|
| Free Cash Flow Margin | -24.30% | 10.97% | -21.82% | -34.11% | -30.28% | Upgrade
|
| Free Cash Flow Per Share | -0.05 | 0.03 | -0.09 | -0.11 | -0.12 | Upgrade
|
| Cash Interest Paid | 0.13 | 0.51 | 0.38 | - | - | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.1 | 0.63 | Upgrade
|
| Levered Free Cash Flow | -0.17 | 2.28 | -1.04 | 0.7 | -0.78 | Upgrade
|
| Unlevered Free Cash Flow | 0.21 | 2.61 | -1.07 | 0.11 | -0.23 | Upgrade
|
| Change in Working Capital | 1.11 | 3.2 | 0.25 | 2.16 | 2.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.